Barlow, LaMont J <br/><br/>
Experience with newer intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer.  [electronic resource] 

 -  Current urology reports  Apr 2013 
 - 65-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1534-6285 
<br/><br/><label>Standard No.: </label>10.1007/s11934-013-0312-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Antineoplastic Agents--therapeutic use<br/>BCG Vaccine--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Docetaxel<br/>Doxorubicin--analogs & derivatives<br/>Humans<br/>Mitomycin--therapeutic use<br/>Paclitaxel--therapeutic use<br/>Taxoids--therapeutic use<br/>Thiotepa--therapeutic use<br/>Treatment Failure<br/>Urinary Bladder Neoplasms--drug therapy<br/>Gemcitabine